Related Experiment Videos
G209A mutant alpha synuclein expression specifically enhances dopamine induced oxidative damage
M Orth1, S J Tabrizi, C Tomlinson
1University Department of Clinical Neurosciences, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK.
Neurochemistry International
|July 6, 2004
Summary
Alpha-synuclein expression may protect against oxidative stress, but the G209A mutation impairs this function. Mutant alpha-synuclein enhances dopamine-induced oxidative damage, potentially contributing to Parkinson's disease.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Alpha-synuclein is implicated in Parkinson's disease (PD) pathogenesis.
- Oxidative stress is a key factor in neurodegeneration observed in PD.
Purpose of the Study:
- To investigate the role of wild-type and G209A mutant alpha-synuclein in cellular oxidative stress.
- To determine the impact of alpha-synuclein expression on oxidative damage induced by dopamine and paraquat.
Main Methods:
- HEK293 cell models with induced expression of wild-type or G209A mutant alpha-synuclein.
- Measurement of oxidative stress markers (glutathione levels, aconitase activity).
- Assessment of cellular response to dopamine and paraquat exposure.
Main Results:
- Alpha-synuclein expression alone did not affect basal oxidative stress levels.
- Both wild-type and mutant alpha-synuclein offered protection against paraquat-induced oxidative damage, with reduced efficacy for the mutant form.
- Mutant alpha-synuclein expression exacerbated dopamine-induced oxidative damage, suggesting impaired dopamine compartmentalization.
Conclusions:
- Alpha-synuclein may possess antioxidant properties, a function diminished by the G209A mutation.
- Mutant alpha-synuclein's disruption of dopamine compartmentalization may lead to selective dopaminergic cell damage in Parkinson's disease.